OA12856A - Androgen pharmaceutical composition and method for treating depression. - Google Patents
Androgen pharmaceutical composition and method for treating depression. Download PDFInfo
- Publication number
- OA12856A OA12856A OA1200400248A OA1200400248A OA12856A OA 12856 A OA12856 A OA 12856A OA 1200400248 A OA1200400248 A OA 1200400248A OA 1200400248 A OA1200400248 A OA 1200400248A OA 12856 A OA12856 A OA 12856A
- Authority
- OA
- OAPI
- Prior art keywords
- day
- testosterone
- androgel
- composition
- sérum
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/098,232 US20040002482A1 (en) | 2000-08-30 | 2002-03-15 | Androgen pharmaceutical composition and method for treating depression |
US10/153,468 US20040092494A9 (en) | 2000-08-30 | 2002-05-21 | Method of increasing testosterone and related steroid concentrations in women |
Publications (1)
Publication Number | Publication Date |
---|---|
OA12856A true OA12856A (en) | 2006-09-15 |
Family
ID=34192609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA1200400248A OA12856A (en) | 2002-03-15 | 2003-03-14 | Androgen pharmaceutical composition and method for treating depression. |
Country Status (12)
Country | Link |
---|---|
US (2) | US20090318398A1 (no) |
AR (1) | AR036970A1 (no) |
BR (1) | BR0308584A (no) |
EA (1) | EA007431B1 (no) |
HK (1) | HK1082677A1 (no) |
IL (3) | IL163981A0 (no) |
NO (1) | NO345056B1 (no) |
NZ (1) | NZ535368A (no) |
OA (1) | OA12856A (no) |
TW (1) | TWI339122B (no) |
UA (1) | UA80964C2 (no) |
ZA (1) | ZA200407403B (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040002482A1 (en) * | 2000-08-30 | 2004-01-01 | Dudley Robert E. | Androgen pharmaceutical composition and method for treating depression |
US6503894B1 (en) * | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
US20040259852A1 (en) | 2003-06-18 | 2004-12-23 | White Hillary D. | Trandsdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome |
US8883769B2 (en) | 2003-06-18 | 2014-11-11 | White Mountain Pharma, Inc. | Methods for the treatment of fibromyalgia and chronic fatigue syndrome |
ES2258694T3 (es) | 2003-11-11 | 2006-09-01 | Mattern, Udo | Sistema de administracion de liberacion controlada de hormonas sexuales para aplicaciones nasales. |
ZA200803087B (en) | 2005-10-12 | 2009-11-25 | Unimed Pharmaceuticals Llc | Improved testosterone gel and method of use |
US20100144687A1 (en) | 2008-12-05 | 2010-06-10 | Glaser Rebecca L | Pharmaceutical compositions containing testosterone and an aromatase inhibitor |
WO2012068410A1 (en) | 2010-11-18 | 2012-05-24 | White Mountain Pharma, Inc. | Methods for treating chronic or unresolvable pain and/or increasing the pain threshold in a subject and pharmaceutical compositions for use therein |
US9757388B2 (en) | 2011-05-13 | 2017-09-12 | Acerus Pharmaceuticals Srl | Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels |
US20130045958A1 (en) | 2011-05-13 | 2013-02-21 | Trimel Pharmaceuticals Corporation | Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
US20130040923A1 (en) | 2011-05-13 | 2013-02-14 | Trimel Pharmaceuticals Corporation | Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
US11744838B2 (en) | 2013-03-15 | 2023-09-05 | Acerus Biopharma Inc. | Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4861764A (en) * | 1986-11-17 | 1989-08-29 | Macro Chem. Corp. | Percutaneous absorption enhancers, compositions containing same and method of use |
US5238944A (en) * | 1988-12-15 | 1993-08-24 | Riker Laboratories, Inc. | Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine |
HU221589B (hu) * | 1989-03-10 | 2002-11-28 | Endorecherche Inc. | Emlő- és méhrák kezelésére alkalmas kombinációs gyógyszerkészítmény és eljárás előállítására |
US5788983A (en) * | 1989-04-03 | 1998-08-04 | Rutgers, The State University Of New Jersey | Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes |
US5152997A (en) * | 1990-12-11 | 1992-10-06 | Theratech, Inc. | Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels |
US5698589A (en) * | 1993-06-01 | 1997-12-16 | International Medical Innovations, Inc. | Water-based topical cream containing nitroglycerin and method of preparation and use thereof |
PT781122E (pt) * | 1994-09-14 | 2000-11-30 | Minnesota Mining & Mfg | Matriz para a distribuicao transdermica de farmacos |
US5730987A (en) * | 1996-06-10 | 1998-03-24 | Omar; Lotfy Ismail | Medication for impotence containing lyophilized roe and a powdered extract of Ginkgo biloba |
US5760096A (en) * | 1996-10-18 | 1998-06-02 | Thornfeldt; Carl R. | Potent penetration enhancers |
US6019997A (en) * | 1997-01-09 | 2000-02-01 | Minnesota Mining And Manufacturing | Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents |
BR9807828A (pt) * | 1997-02-07 | 2000-03-08 | Theratech Inc | Composições e método para a suplementação de testosterona em mulheres com sintomas de deficiência de testosterona |
PT1510213E (pt) * | 1997-11-10 | 2009-02-12 | Strakan Internat Ltd Uma Socie | Sistemas de melhoramento de penetração e reduzida irritação incluíndo testosterona |
US6200591B1 (en) * | 1998-06-25 | 2001-03-13 | Anwar A. Hussain | Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction |
US5880117A (en) * | 1998-07-13 | 1999-03-09 | Arnold; Patrick | Use of 4-androstenediol to increase testosterone levels in humans |
US20040092494A9 (en) * | 2000-08-30 | 2004-05-13 | Dudley Robert E. | Method of increasing testosterone and related steroid concentrations in women |
US6503894B1 (en) * | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
PT1322336E (pt) * | 2000-08-30 | 2013-08-05 | Unimed Pharmaceuticals Llc | Método de aumentar as concentrações de testosterona e esteróides relacionados em mulheres |
US20040002482A1 (en) * | 2000-08-30 | 2004-01-01 | Dudley Robert E. | Androgen pharmaceutical composition and method for treating depression |
US20030027804A1 (en) * | 2001-06-27 | 2003-02-06 | Van Der Hoop Roland Gerritsen | Therapeutic combinations for the treatment of hormone deficiencies |
US20040072810A1 (en) * | 2001-11-07 | 2004-04-15 | Besins International Belgique | Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof |
FR2848112B1 (fr) * | 2002-12-10 | 2007-02-16 | Besins Int Belgique | Composition pharmaceutique pour administration transdermique ou transmuqueuse comprenant au moins un progestatif et/ou au moins un oestrogene, son procede de preparation et ses utilisations |
FR2851470B1 (fr) * | 2003-02-20 | 2007-11-16 | Besins Int Belgique | Composition pharmaceutique pour administration transdermique ou transmuqueuse |
US20050020552A1 (en) * | 2003-07-16 | 2005-01-27 | Chaim Aschkenasy | Pharmaceutical composition and method for transdermal drug delivery |
ZA200803087B (en) * | 2005-10-12 | 2009-11-25 | Unimed Pharmaceuticals Llc | Improved testosterone gel and method of use |
WO2008032718A1 (fr) * | 2006-09-11 | 2008-03-20 | Sekisui Chemical Co., Ltd. | Préparation adhésive |
-
2003
- 2003-03-14 OA OA1200400248A patent/OA12856A/en unknown
- 2003-03-14 TW TW092105579A patent/TWI339122B/zh not_active IP Right Cessation
- 2003-03-14 IL IL16398103A patent/IL163981A0/xx unknown
- 2003-03-14 BR BR0308584-8A patent/BR0308584A/pt not_active Application Discontinuation
- 2003-03-14 NZ NZ535368A patent/NZ535368A/en not_active IP Right Cessation
- 2003-03-14 EA EA200401210A patent/EA007431B1/ru unknown
- 2003-03-14 AR ARP030100900A patent/AR036970A1/es not_active Application Discontinuation
- 2003-03-14 UA UA20040907532A patent/UA80964C2/uk unknown
- 2003-03-14 ZA ZA200407403A patent/ZA200407403B/en unknown
-
2004
- 2004-09-09 IL IL163981A patent/IL163981A/en active IP Right Grant
- 2004-10-13 NO NO20044342A patent/NO345056B1/no not_active IP Right Cessation
-
2006
- 2006-02-08 HK HK06101668.3A patent/HK1082677A1/xx not_active IP Right Cessation
-
2009
- 2009-08-19 US US12/543,541 patent/US20090318398A1/en not_active Abandoned
-
2011
- 2011-06-21 US US13/165,545 patent/US20110306582A1/en not_active Abandoned
- 2011-10-26 IL IL215944A patent/IL215944A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
IL163981A (en) | 2011-11-30 |
IL163981A0 (en) | 2005-12-18 |
EA200401210A1 (ru) | 2005-08-25 |
AR036970A1 (es) | 2004-10-20 |
HK1082677A1 (en) | 2006-06-16 |
ZA200407403B (en) | 2007-09-26 |
IL215944A (en) | 2014-09-30 |
TW200412976A (en) | 2004-08-01 |
NO20044342L (no) | 2004-12-06 |
EA007431B1 (ru) | 2006-10-27 |
TWI339122B (en) | 2011-03-21 |
BR0308584A (pt) | 2005-02-22 |
NZ535368A (en) | 2007-06-29 |
NO345056B1 (no) | 2020-09-07 |
UA80964C2 (en) | 2007-11-26 |
IL215944A0 (en) | 2011-12-29 |
US20090318398A1 (en) | 2009-12-24 |
US20110306582A1 (en) | 2011-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20150250801A1 (en) | Androgen pharmaceutical composition and method for treating depression | |
US20110306582A1 (en) | Androgen pharmaceutical composition and method for treating depression | |
AU2001286995B2 (en) | Method for treating erectile dysfunction and increasing libido in men | |
US20050049233A1 (en) | Method for treating erectile dysfunction and increasing libido in men | |
CA2451725C (en) | Therapeutic combinations for the treatment of hormone deficiencies | |
AU2001285367B2 (en) | Method of increasing testosterone and related steroid concentrations in women | |
US20050152956A1 (en) | Method of increasing testosterone and related steroid concentrations in women | |
ZA200301687B (en) | Method for treating erectile dysfunction and increasing libido in men. | |
AU2003228314B8 (en) | Androgen pharmaceutical composition and method for treating depression | |
CA2498267C (en) | Method for treating erectile dysfunction and increasing libido in men |